iShares Global Healthcare ETF (IXJ)

  • Loading...
#11

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 16 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Good
Tracking Error Typical
Bid/Ask Ratio Good
Holdings Diversity Good

Fund Description

The investment seeks to track the investment results of an index composed of global equities in the healthcare sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the S&P Global 1200 Healthcare Sector IndexTM (the "underlying index"), which measures the performance of companies that S&P Dow Jones Indices LLC ("S&P"), deems to be a part of the healthcare sector of the economy and that S&P believes are important to global markets. The fund is non-diversified.

Fund Snapshot Updated 04.23.2014

Previous Close $90.41 Expense Ratio 0.48%
YTD Return 5.04% Avg. 30-Day Volume 65,493
1-Year Return 20.4% Market Cap Loading...
Bid $90.46 Shares Outstanding 12,550,000
Ask $90.49 Dividends $1.30
Top 10 Holdings
Johnson & Johnson (JNJ) 7.96%
Novartis Ag (E:NOVN) 6.57%
Roche Hldgs Ag (E:ROG) 5.73%
Pfizer Inc (PFE) 5.54%
Merck & Co Inc New (MRK) 4.75%
Glaxosmithkline (E:GSK) 3.80%
Sanofi (E:SAN) 3.63%
Gilead Sciences Inc (GILD) 3.19%
Bayer Ag (E:BAYN) 3.11%
Novo-Nordisk As (NOVO-B) 2.71%
% of Total Holdings 47.00%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds